| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/15/2007 | WO2006081139A3 Antibodies against interleukin-1 beta |
| 02/15/2007 | WO2006076480A3 Tergeted apheresis for the treatment of rheumaoid arthritis |
| 02/15/2007 | WO2006071933A3 Hetero-oligomeric hiv envelope proteins |
| 02/15/2007 | WO2006062928A3 Live genetically engineered protozoan vaccine |
| 02/15/2007 | WO2006011151A3 Vaccine comprising recombinant ct or lt toxin |
| 02/15/2007 | WO2006008639A8 Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody |
| 02/15/2007 | WO2005121378A3 Methods and compositions for vaccination |
| 02/15/2007 | WO2005013904A3 Sars nucleic acids, proteins, vaccines, and uses thereof |
| 02/15/2007 | US20070037967 conjugated by bridging molecules to proteins or polypeptides, reporter groups or cytotoxic agents; cancer |
| 02/15/2007 | US20070037825 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 02/15/2007 | US20070037766 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 02/15/2007 | US20070037749 Administering a N-terminus modified polypeptide derived from the fibrin alpha or beta chain; antiinflammatory agent, anticoagulants; transplant rejection; arteriosclerosis |
| 02/15/2007 | US20070037745 Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer |
| 02/15/2007 | US20070037741 Novel compositions and methods for the treatment of immune related disease |
| 02/15/2007 | US20070037257 Nucleic acid, expression vectors and host cells for synthetic genes, chosen from a gram negative bacteria, yeast, or mammalian cell; zinc-endopeptidases that specifically cleave the synaptosomal proteins, SNAP-25, VAMP, or syntaxin at discrete sites |
| 02/15/2007 | US20070037250 Method for obtaining precursor Z and use thereof for the production of a means for therapy of human molybdenum cofactor deficiency |
| 02/15/2007 | US20070037227 Annexin proteins and autoantibodies as serum markers for cancer |
| 02/15/2007 | US20070037158 Methods of modulating bone growth, bone remodeling and adiposity |
| 02/15/2007 | US20070037151 Cd4+ human papillomavirus (hpv) epitopes |
| 02/15/2007 | US20070037147 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 02/15/2007 | US20070037145 drug screening; for carcinomas, especially lymphoma carcinomas |
| 02/15/2007 | US20070037141 comprise DP178 peptide corresponding to amino acids 638 to 673 of the HIV-1LAI gp41 protein; inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells |
| 02/15/2007 | US20070036828 Group b streptococcus vaccine |
| 02/15/2007 | US20070036827 West nile virus vaccine |
| 02/15/2007 | US20070036826 Influenza immunogen and vaccine |
| 02/15/2007 | US20070036825 Flavivirus NS5A proteins for the treatment of HIV |
| 02/15/2007 | US20070036824 Optimized expression of hpv 58 l1 in yeast |
| 02/15/2007 | US20070036823 Development of a live, attenuated, recombinant vaccine for Brucellosis |
| 02/15/2007 | US20070036822 Selection system containing non-antibiotic resistance selection marker |
| 02/15/2007 | US20070036819 Plasmodium placental polypeptide for use in generating vaccine for treatment and prevention of malarial infection |
| 02/15/2007 | US20070036818 Fabricated in baculovirus; for penetration into human erythrocytes in event of infection; vaccines against malaria |
| 02/15/2007 | US20070036817 Immunopotentiating effect of a fomitella fraxinea-derived lectin on chicken immunity and resistance to coccidiosis |
| 02/15/2007 | US20070036816 Tuberculosis antigen detection assays and vaccines |
| 02/15/2007 | US20070036815 Ricin-like toxins for treatment of cancer |
| 02/15/2007 | US20070036814 Antibody binding to polypeptide of given sequence; antisera; use in wound healing, blocking adherence to indwelling medical devices, vaccines |
| 02/15/2007 | US20070036813 Expression vector comprising nucleotide sequences coding endothelial growth factor protein for use in prevention and treatment of cell proliferative and eye disorders |
| 02/15/2007 | US20070036812 polypeptide with binding to antigen and is recognized by cytotoxic T lymphocytes; use as cancer vaccine |
| 02/15/2007 | US20070036811 autoimmune disorders; human leukocyte antigen |
| 02/15/2007 | US20070036810 Cyclic amp response element activator proteins and uses related thereto |
| 02/15/2007 | US20070036809 Tolerance-induced targeted antibody production |
| 02/15/2007 | US20070036808 Cancer antigen peptide formulations |
| 02/15/2007 | US20070036807 freezing dried biochemical conjugated immunomodulator comprising immunostimulatory polynucleotide sequence and plant Ragweed allergen; genetic vaccines |
| 02/15/2007 | US20070036806 have an increased half-life, decreased immunogenicity, and reduce effector activity; diabetes, obesity, irritable bowel syndrome and other conditions that would be benefited by lowering plasma glucose, inhibiting gastric and/or intestinal motility and inhibiting gastric and/or intestinal emptying |
| 02/15/2007 | US20070036805 Comprising a specific binding agent which is an F(ab')2 or F(ab)2 antibody fragment that specifically binds a target toxin, and a second specific binding agent that comprises a small binding antibody fragment that binds the target toxin; Botulinum toxin |
| 02/15/2007 | US20070036804 Novel methods of cancer diagnosis and therapy targeted against a cancer stem line |
| 02/15/2007 | US20070036803 Novel methods of cancer diagnosis and therapy targeted against a cancer stem line |
| 02/15/2007 | US20070036802 Novel methods of cancer diagnosis and therapy targeted against a cancer stem line |
| 02/15/2007 | US20070036801 Targetting slow-growing, relatively mutationally-spared cancer; one-step genetic switches; antiproliferative agents; magnetic resonance imaging |
| 02/15/2007 | US20070036800 Targeting slow-growing, relatively mutationally spared cancer stem line; early cancer treatment and reduce the likelihood of clinical relapse |
| 02/15/2007 | US20070036799 Identification and engineering of antibodies with variant Fc regions and methods of using same |
| 02/15/2007 | US20070036798 Method and composition for reconforming multi-epitopic antigens to initiate an immune response |
| 02/15/2007 | US20070036797 Methods of treating brain tumors with antibodies |
| 02/15/2007 | US20070036796 For treating immunosuppressive diseases; AIDS |
| 02/15/2007 | US20070036795 Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular agonist |
| 02/15/2007 | US20070036794 Agonist anti-trkC monoclonal antibodies, directed against epitopes in extracellular domain of trkC receptor, which mimic biological activities of NT-3, the natural ligand of trkC receptor, but are free of some of known detriments of NT-3; use of theseagonist antibodies treatment of neuropathy |
| 02/15/2007 | US20070036793 Methods for use of an lkb1/strad7mo25 complex |
| 02/15/2007 | US20070036792 Antibodies that specifically bind to Reg IV |
| 02/15/2007 | US20070036791 Interleukin-17 receptor homologue |
| 02/15/2007 | US20070036790 Treatment with anti-vegf antibodies |
| 02/15/2007 | US20070036789 Neutralizable Epitope of HGF and Neutralizing Antibody Binding to the Same |
| 02/15/2007 | US20070036788 Use of a compound for reducing the biological effectiveness of il-6 |
| 02/15/2007 | US20070036787 Insulin-induced gene as therapeutic target in diabetes |
| 02/15/2007 | US20070036786 Method of treating autoimmune disease using humanized anti-CD16A antibodies |
| 02/15/2007 | US20070036785 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 02/15/2007 | US20070036784 Medicament for the protection against thrombotic diseases |
| 02/15/2007 | US20070036783 Antibody complexes |
| 02/15/2007 | US20070036782 Apo-2 ligand |
| 02/15/2007 | US20070036781 Ligands |
| 02/15/2007 | US20070036780 Modified proteins, designer toxins, and methods of making thereof |
| 02/15/2007 | US20070036779 Stabilising formulation for immunoglobulin g compositions in liquid form and in lyophilised form |
| 02/15/2007 | US20070036778 Staphylococcus; immunogens; immumostimulatory sequences; cationic peptides |
| 02/15/2007 | US20070036755 Treatment with anti-vegf antibodies |
| 02/15/2007 | US20070036754 Treatment with anti-vegf antibodies |
| 02/15/2007 | US20070036753 Treatment with anti-vegf antibodies |
| 02/15/2007 | US20070036751 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
| 02/15/2007 | US20070036750 MCP1 fusions |
| 02/15/2007 | US20070036734 Therapeutic agent for periodontal disease |
| 02/15/2007 | US20070036722 Separation processes |
| 02/15/2007 | US20070036719 antibodies and their use for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis; prostate specific membrane antigen (PSMA) |
| 02/15/2007 | US20070034214 Method to affect the development of autism spectrum disorders |
| 02/15/2007 | CA2658678A1 Composition and method for prevention and treatment of type i diabetes |
| 02/15/2007 | CA2618796A1 Tcr-v-beta related peptides for treatment and diagnosis of autoimmune disease |
| 02/15/2007 | CA2618694A1 Genes from actinobacillus succinogenes 13oz (atcc 55618) for production of chemicals from the a. succinogenes c4-pathway |
| 02/15/2007 | CA2618554A1 Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| 02/15/2007 | CA2618542A1 Prophylactic/therapeutic agent for cancer |
| 02/15/2007 | CA2618093A1 Composition and method for use in cartilage affecting conditions |
| 02/15/2007 | CA2617905A1 Methods and compositions for treating female infertility using clomiphene |
| 02/15/2007 | CA2617807A1 Methods for treating and detecting beta-cell disease |
| 02/15/2007 | CA2617508A1 Virus-like particles as vaccines for paramyxovirus |
| 02/15/2007 | CA2617506A1 Immunogenic constructs useful for treating mycobacterium avium subspecies paratuberculosis (map) infection |
| 02/15/2007 | CA2616902A1 Human inhibitory anti-factor viii antibodies binding to the a2 domain |
| 02/15/2007 | CA2615776A1 Secretion of antibodies without signal peptides from bacteria |
| 02/15/2007 | CA2615687A1 Immune response inducing preparations |
| 02/15/2007 | CA2615460A1 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility |
| 02/15/2007 | CA2615122A1 Immunoconjugate formulations |
| 02/15/2007 | CA2613482A1 Methods and compositions for diagnosis and treatment of influenza |
| 02/15/2007 | CA2583274A1 Enhancement of b cell proliferation by il-15 |
| 02/14/2007 | WO2008019162A2 Compositions and methods related to staphylococcal bacterium proteins |
| 02/14/2007 | EP1752472A2 Chimeric amyloid beta peptides |
| 02/14/2007 | EP1752468A1 Method for the production of empty viral capsids in yeasts, said capsids comprising proteins derived from pvp2 of the virus that causes infectious bursal disease (ibdv) |